Combination product development in focus at PFS and IDD East Coast 2026
March 13 2026
![[.png] Landmark view of Boston, host city of the Pre-filled Syringes and Injectable Drug Devices East Coast 2026 conference, where SHL Medical will take part.](https://cdn.bfldr.com/DTG6CG68/at/n7w3qpwsshb5p9j8mrphf9k/combination-product-development-focus-pfs-idd-east-coast-2026-banner.png?width=480&auto=webp&format=webp)
SHL Medical will participate in the Pre-filled Syringes and Injectable Drug Devices East Coast 2026 conference, taking place from April 27-29 in Boston, USA.
At the conference, we will showcase our device solutions and share insights into platform-based approaches for combination product development. Our Senior Vice President of Innovation and Product Strategy, Bart Burgess, will present on the evolving cardiometabolic disease landscape and its role in shaping the development of Quanta, our patient-centric peptide delivery system.
With manufacturing facilities in North Charleston and Deerfield Beach, SHL Medical provides pharma partners with manufacturing support aligned with local market needs, helping ensure reliable and consistent supply.
Register to join us at PFS and IDD East Coast 2026 and exchange insights on combination product development and drug delivery innovation.
Meet our speaker
|
Topic |
Speaker |
Time |
|
Making Multi-Dose Peptide Delivery Work at Scale: Device and Production Realities |
Bart Burgess Senior Vice President of Innovation and Product Strategy, SHL Medical |
April 29 9:00 AM EDT |
Where : Sheraton Boston Hotel, Boston, USA
When : April 27-29